News
Lymph2Cx assay identifies outcomes in DLBCL
Key clinical point: The Lymph2Cx is an accurate assay for DLBCL cell of origin assignment, and identified groups with significantly different...
News
Docetaxel added to ADT extends survival from prostate cancer
Key clinical point: Androgen deprivation therapy plus six cycles of docetaxel resulted in significantly longer overall survival compared with ADT...
News
R-ISS identifies three survival patterns in multiple myeloma
Key clinical point: The R-ISS staging system allows for improved risk stratification in newly diagnosed patients with multiple myeloma. Major...
News
Anticoagulant therapy not contraindicated in brain metastases
Treatment of venous thromboembolism with anticoagulation does not increase the risk of intracranial hemorrhage in cancer patients with metastasis...
News
ASCO guidelines define use of biomarkers for advanced breast cancer treatment
New guidelines from the American Society of Clinical Oncology provide evidence based recommendations on the appropriate use of biomarkers in the...
News
Age and tumor site impact outcome in rare ovarian cancer
Younger age, tumor site in the ovary, and disease persistence following completion of primary therapy were all associated with poorer outcomes.